Balentine LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,206	Closed	-$228K	–	609
2022 Q4	$228K	Sell	2,206 -212	-9%	-$19.9K	0.01%	503
2022 Q3	$205K	Sell	2,418 -296	-11%	-$26.4K	0.01%	483
2022 Q2	$225K	Buy	+2,714	New	+$216K	0.01%	506
2020 Q3	–	Sell	-28	Closed	-$3K	–	237
2020 Q2	$3K	Sell	28 -248	-90%	-$24.6K	﹤0.01%	786
2020 Q1	$23K	Buy	+276	New	+$23.8K	﹤0.01%	254
2019 Q4	–	Sell	-37	Closed	-$2K	–	616
2019 Q3	$2K	Buy	+37	New	+$2.85K	﹤0.01%	631
2018 Q1	–	Sell	-42	Closed	-$4K	–	120
2017 Q4	$4K	Sell	42 -45	-52%	-$3.91K	﹤0.01%	531
2017 Q3	$8K	Hold	87	–	–	﹤0.01%	482
2017 Q2	$8K	Hold	87	–	–	﹤0.01%	459
2017 Q1	$8K	Buy	87 +42	+93%	+$3.74K	﹤0.01%	432
2016 Q4	$4K	Buy	45 +10	+29%	+$860	﹤0.01%	455
2016 Q3	$3K	Hold	35	–	–	﹤0.01%	421
2016 Q2	$3K	Hold	35	–	–	﹤0.01%	414
2016 Q1	$3K	Hold	35	–	–	﹤0.01%	308
2015 Q4	$4K	Buy	35 +8	+30%	+$835	﹤0.01%	390
2015 Q3	$3K	Buy	+27	New	+$3.61K	﹤0.01%	432